We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$21.7B
AUM Growth
+$654M
Cap. Flow
+$134M
Cap. Flow %
0.62%
Top 10 Hldgs %
19.95%
Holding
1,730
New
406
Increased
584
Reduced
356
Closed
349

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$357M
2
C icon
Citigroup
C
+$340M
3
BAC icon
Bank of America
BAC
+$335M
4
PG icon
Procter & Gamble
PG
+$221M
5
VOD icon
Vodafone
VOD
+$203M

Sector Composition

Rank Sector Weight
1 Technology 22.32%
2 Consumer Staples 14.02%
3 Financials 11.21%
4 Consumer Discretionary 11.1%
5 Communication Services 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
126
DexCom
DXCM
$32B
$37.2M 0.17%
1,818,532
+148,500
+9% +$3.09M
IBM icon
127
IBM
IBM
$224B
$36.9M 0.17%
280,242
-871,303
-76% -$117M
UNM icon
128
Unum
UNM
$14.3B
$36.5M 0.17%
1,096,930
-115,368
-10% -$3.98M
BMRN icon
129
BioMarin Pharmaceuticals
BMRN
$12.4B
$35.8M 0.16%
341,349
-5,319
-2% -$555K
ASML icon
130
ASML
ASML
$669B
$35.4M 0.16%
+398,723
New +$36.3M
ISRG icon
131
Intuitive Surgical
ISRG
$134B
$35.3M 0.16%
581,940
-153,513
-21% -$8.62M
MANH icon
132
Manhattan Associates
MANH
$11.4B
$35M 0.16%
529,201
+338,801
+178% +$24.1M
PPC icon
133
Pilgrim's Pride
PPC
$6.54B
$35M 0.16%
1,582,780
-99,885
-6% -$2.04M
TXT icon
134
Textron
TXT
$15.4B
$34.3M 0.16%
816,359
-123,143
-13% -$5.09M
VRSN icon
135
VeriSign
VRSN
$26.6B
$34M 0.16%
389,130
+203,450
+110% +$17M
ADI icon
136
Analog Devices
ADI
$190B
$33.8M 0.16%
611,819
+560,119
+1,083% +$33M
GD icon
137
General Dynamics
GD
$106B
$33.8M 0.16%
245,737
-46,763
-16% -$6.68M
TEVA icon
138
Teva Pharmaceuticals
TEVA
$41.2B
$33.4M 0.15%
509,420
-1,388,048
-73% -$85.8M
GGAL icon
139
Galicia Financial Group
GGAL
$7.42B
$33.2M 0.15%
1,225,560
-6,700
-0.5% -$161K
EL icon
140
Estee Lauder
EL
$32B
$33.1M 0.15%
376,378
-103,611
-22% -$8.82M
AZN icon
141
AstraZeneca
AZN
$250B
$33.1M 0.15%
487,758
-669,684
-58% -$43.9M
DATA
142
DELISTED
Tableau Software, Inc.
DATA
$32.7M 0.15%
346,686
+192,183
+124% +$17.3M
FLEX icon
143
Flex
FLEX
$44.8B
$32.6M 0.15%
3,855,878
+1,400,892
+57% +$11.8M
LRCX icon
144
Lam Research
LRCX
$390B
$32.5M 0.15%
4,088,980
+2,590,980
+173% +$19.5M
MAC icon
145
Macerich
MAC
$6.92B
$32.4M 0.15%
401,821
+220,196
+121% +$17.7M
CSX icon
146
CSX Corp
CSX
$93.1B
$31.9M 0.15%
3,685,896
-1,970,004
-35% -$17.9M
ROK icon
147
Rockwell Automation
ROK
$49B
$31.8M 0.15%
309,516
-39,133
-11% -$4.1M
IM
148
DELISTED
Ingram Micro
IM
$31.7M 0.15%
1,043,928
+676,065
+184% +$20.5M
MXIM
149
DELISTED
Maxim Integrated Products
MXIM
$31.5M 0.14%
827,887
+284,703
+52% +$10.9M
CTXS
150
DELISTED
Citrix Systems Inc
CTXS
$30.9M 0.14%
513,473
+66,760
+15% +$4.1M

Similar funds

Arrowstreet Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Arrowstreet Capital held 1,730 positions worth $21.7B, up 3.1% from $21.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arrowstreet Capital's Q4 2015 filing shows 406 new, 584 increased, 356 reduced and 349 closed positions. Its largest new stake was Netflix: 15,233,700 shares worth $174M. The largest sale was Apple, an estimated $357M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 14% a quarter earlier, followed by Consumer Staples and Financials.

  • Arrowstreet Capital's largest Q4 2015 buy was Netflix: 15,233,700 shares worth $174M.
  • Arrowstreet Capital added most to Meta Platforms (Facebook) in Q4 2015, an estimated $449M increase.
  • Arrowstreet Capital's biggest Q4 2015 reduction was Apple, cutting an estimated $357M.
  • Arrowstreet Capital fully exited Celgene Corp in Q4 2015, selling an estimated $164M.
  • Arrowstreet Capital's ten largest holdings make up 20% of its $21.7B portfolio in Q4 2015.
  • Arrowstreet Capital opened 406 new positions and closed 349 in Q4 2015.
  • Arrowstreet Capital's portfolio value rose 3.1% quarter-over-quarter to $21.7B.

Based on Arrowstreet Capital's 13F filing for Q4 2015, filed 16 Feb 2016.